Prevalence and Clinical Course in Invasive Infections with Meningococcal Endotoxin Variants

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Rodenburg, Gerwin D ^a   Fransen, Floris ^b,c   Bogaert, Debby ^a   Schipper, Kim ^d   Groenwold, Rolf H H ^e   Hamstra, Hendrik Jan ^b   Westerhuis, Brenda M ^b   van de Beek, Diederik ^d   van der Ley, Peter ^b   Sanders, Elisabeth A M ^a   van der Ende, Arie ^d  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; INTERLEUKIN 6; LIPID A;

ADULT; AGE; ARTICLE; BACTERIAL GENE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIUM ISOLATE; COMORBIDITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; IPXL1 GENE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN;

ACYLTRANSFERASES; ADOLESCENT; ADULT; AGE FACTORS; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; LIPID A; MENINGOCOCCAL INFECTIONS; MIDDLE AGED; MUTATION; NEISSERIA MENINGITIDIS; PREVALENCE; SEROTYPING; YOUNG ADULT;

EID: 84870519881     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0049295     Document Type: Article

References (27)

1. Yazdankhah SP, Kriz P, Tzanakaki G, Kremastinou J, Kalmusova J, et al. (2004) Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and Norway. J Clin Microbiol 42: 5146-5153.
2. Claus H, Maiden MC, Wilson DJ, McCarthy ND, Jolley KA, et al. (2005) Genetic analysis of meningococci carried by children and young adults. J Infect Dis 191: 1263-1271.
3. Stephens DS, Greenwood B, Brandtzaeg P, (2007) Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 369: 2196-2210.
4. de Greeff SC, de Melker HE, Schouls LM, Spanjaard L, van Deuren M, (2008) Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005. Eur J Clin Microbiol Infect Dis 27: 985-992.
5. Trotter CL, Chandra M, Cano R, Larrauri A, Ramsay ME, et al. (2007) A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 31: 27-36.
6. Goldschneider I, Gotschlich EC, Artenstein MS, (1969) Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 129: 1307-1326.
7. Pollard AJ, Frasch C, (2001) Development of natural immunity to Neisseria meningitidis. Vaccine 19: 1327-1346.
8. Tully J, Viner RM, Coen PG, Stuart JM, Zambon M, et al. (2006) Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ 332: 445-450.
9. Heckenberg SG, de Gans J, Brouwer MC, Weisfelt M, Piet JR, et al. (2008) Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine (Baltimore) 87: 185-192.
10. Harrison LH, Trotter CL, Ramsay ME, (2009) Global epidemiology of meningococcal disease. Vaccine 27 Suppl 2: B51-B63.
11. Beutler B, Rietschel ET, (2003) Innate immune sensing and its roots: the story of endotoxin. Nat Rev Immunol 3: 169-176.
12. Bryant CE, Spring DR, Gangloff M, Gay NJ, (2010) The molecular basis of the host response to lipopolysaccharide. Nat Rev Microbiol 8: 8-14.
13. Zughaier SM, Tzeng YL, Zimmer SM, Datta A, Carlson RW, et al. (2004) Neisseria meningitidis lipooligosaccharide structure-dependent activation of the macrophage CD14/Toll-like receptor 4 pathway. Infect Immun 72: 371-380.
14. Sprong T, Stikkelbroeck N, van der Ley P, Steeghs L, van Alphen L, et al. (2001) Contributions of Neisseria meningitidis LPS and non-LPS to proinflammatory cytokine response. J Leukoc Biol 70: 283-288.
15. Fransen F, Heckenberg SG, Hamstra HJ, Feller M, Boog CJ, et al. (2009) Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog 5: e1000396.
16. van der Ley P, Steeghs L, Hamstra HJ, Ten Hove J, Zomer B, et al. (2001) Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect Immun 69: 5981-5990.
17. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, et al. (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95: 3140-3145.
18. Jolley KA, Chan MS, Maiden MC, (2004) mlstdbNet- distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 5: 86.
19. Ziegler-Heitbrock HW, Thiel E, Futterer A, Herzog V, Wirtz A, et al. (1988) Establishment of a human cell line (Mono Mac 6) with characteristics of mature monocytes. Int J Cancer 41: 456-461.
20. Ernst RK, Adams KN, Moskowitz SM, Kraig GM, Kawasaki K, et al. (2006) The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway. J Bacteriol 188: 191-201.
21. Miller SI, Ernst RK, Bader MW, (2005) LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 3: 36-46.
22. Levy O, (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390.
23. Bogaert D, Weinberger D, Thompson C, Lipsitch M, Malley R, (2009) Impaired innate and adaptive immunity to Streptococcus pneumoniae and its effect on colonization in an infant mouse model. Infect Immun 77: 1613-1622.
24. Lo H, Tang CM, Exley RM, (2009) Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development. Lancet Infect Dis 9: 418-427.
25. Wolfe DN, Buboltz AM, Harvill ET, (2009) Inefficient Toll-like receptor-4 stimulation enables Bordetella parapertussis to avoid host immunity. PLoS One 4: e4280.
26. Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, et al. (2009) Cross-talk between TLR4 and FcgammaReceptorIII (CD16) pathways. PLoS Pathog 5: e1000464.
27. Brandtzaeg P, Bjerre A, Ovstebo R, Brusletto B, Joo GB, et al. (2001) Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res 7: 401-420.